APA (7th ed.) Citation

Qian, Y., Ma, W., & Xu, X. (2025). Breakthrough for Anticancer Immunotherapy: Current Advances in Manufacturing Protocols of Chimeric Antigen Receptor-Based Therapies. Antibodies (2073-4468), 14(4), 105. https://doi.org/10.3390/antib14040105

Chicago Style (17th ed.) Citation

Qian, Yuxin, Weiwei Ma, and Xiao-Ning Xu. "Breakthrough for Anticancer Immunotherapy: Current Advances in Manufacturing Protocols of Chimeric Antigen Receptor-Based Therapies." Antibodies (2073-4468) 14, no. 4 (2025): 105. https://doi.org/10.3390/antib14040105.

MLA (9th ed.) Citation

Qian, Yuxin, et al. "Breakthrough for Anticancer Immunotherapy: Current Advances in Manufacturing Protocols of Chimeric Antigen Receptor-Based Therapies." Antibodies (2073-4468), vol. 14, no. 4, 2025, p. 105, https://doi.org/10.3390/antib14040105.